GenVec president and ceo to retire

US firm hires recruitment firm to find a successor

GenVec, a US biopharmaceutical company that uses differentiated, proprietary technologies to create therapeutics and vaccines, says Paul Fischer plans to retire as president and chief executive. Dr Fischer will continue in the role until a successor is named and the ceo transition is complete. The Board will use Spencer Stuart, an executive search firm, to advise it on potential candidates.

Fischer has been with the Gathersburg, MD firm for 15 years.

You may also like

Manufacturing

WLS introduces PR-12 and PR-24 plunger rod insertion and labelling systems

By improving reliability and streamlining production, the PR-12 and PR-24 help pharmaceutical manufacturers and contract packers protect product quality and reduce waste while maximising operational efficiencies
Pharmaceutical

Azelis strengthens its footprint in Italy with the acquisition of Azienda Chimica e Farmaceutica (‘ACEF’)

Azelis is pleased to announce that it has acquired 100% of the shares of Azienda Chimica e Farmaceutica (‘ACEF’), a distributor of speciality raw materials and ingredients for the cosmetic, nutraceutical, galenic and pharma industries in Italy
Manufacturing

Mettler-Toledo to present solutions designed to Inspect. Protect. Comply. at PPMA Total Show 2025

Mettler-Toledo to demonstrate its proven product inspection solutions designed to boost brand, productivity and profits while complying easily with industry requirements
Manufacturing

Atlas Copco expands oil-free compressor range to support critical pharmaceutical air quality standards

Atlas Copco has expanded its oil-free compressor portfolio with cutting-edge models engineered to exceed pharmaceutical air quality standards and improve energy efficiency across critical manufacturing environments
Design & Build

Roxtec launches airtight cable and pipe seal for cleanrooms, labs, and advanced facilities

Roxtec has developed the LabSeal, a new airtight and fire-rated cable and pipe penetration seal designed for cleanrooms and laboratories in the pharma, biopharma, and biotech industries
Drug Delivery

Neurizon develops oral liquid form of investigational ALS therapy, NUZ-001

The liquid format hopes to improve patient adherence, as well as the administration experience for those with ALS
Pharmaceutical

Putting people first – how CARBOGEN AMCIS builds a culture of commitment

Empowering teams through purpose, leadership development, and global career opportunities
Subscribe now